Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoguo Jin

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Oncology Reports|August 23, 2018
Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse modelHangfan Liu, Jimin Zhao, Yi Yang, et al.
Oncotarget|September 9, 2017
APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse modelGuoguo Jin, Ke Yao, Zhiping Guo, et al.
Molecular Carcinogenesis|February 22, 2019
Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcomaZhenjiang Zhao, Guoguo Jin, Ke Yao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2Xiaochuan Su, Junyan Teng, Guoguo Jin, et al.
Oncogene|September 23, 2020
Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancerGuoguo Jin, Mingyang Yan, Kangdong Liu, et al.
International Journal of Molecular Medicine|November 3, 2018
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathwayDan Li, Gangcheng Wang, Guoguo Jin, et al.
Oncogene|November 9, 2021
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expressionQiong Wu, Fangfang Liu, Mengmeng Ge, et al.
Cell Death & Disease|April 1, 2026
USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancerKexin Zhao, Lei Zhang, Mingyang Yan, et al.
Cancer Cell International|April 4, 2025
Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivoRuoping Yanzhang, Mingyang Yan, Zhaojie Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2025
Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy responseTing Wang, Xiangyu Wang, Keke Wang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Oncology Reports|August 23, 2018
Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse modelHangfan Liu, Jimin Zhao, Yi Yang, et al.
Oncotarget|September 9, 2017
APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse modelGuoguo Jin, Ke Yao, Zhiping Guo, et al.
Molecular Carcinogenesis|February 22, 2019
Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcomaZhenjiang Zhao, Guoguo Jin, Ke Yao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2Xiaochuan Su, Junyan Teng, Guoguo Jin, et al.
Oncogene|September 23, 2020
Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancerGuoguo Jin, Mingyang Yan, Kangdong Liu, et al.
International Journal of Molecular Medicine|November 3, 2018
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathwayDan Li, Gangcheng Wang, Guoguo Jin, et al.
Oncogene|November 9, 2021
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expressionQiong Wu, Fangfang Liu, Mengmeng Ge, et al.
Cell Death & Disease|April 1, 2026
USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancerKexin Zhao, Lei Zhang, Mingyang Yan, et al.
Cancer Cell International|April 4, 2025
Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivoRuoping Yanzhang, Mingyang Yan, Zhaojie Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2025
Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy responseTing Wang, Xiangyu Wang, Keke Wang, et al.
Pageof 4